04/09/2024  17:30:47 Chg. -1.84 Volume Bid21:19:46 Demandez à21:19:46 Capitalisation boursière Dividende Y. Rapport P/E
89.64CHF -2.01% 3.71 Mio.
Chiffrre d'affaires: 335.14 Mio.
-Bid taille: 107 -Ask la taille: 214 239.34 Mrd.CHF 3.35% 21.14

Description de l'entreprise

Nestlé is a science-based Nutrition, Health and Wellness company. The creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences reinforced this strategic direction and focus on helping consumers lead a healthier life through nutritional solutions from food and beverages to life-enhancing scientific products. Responding to increasing consumer needs, Nestlé extended its activities to include the field of specialized, medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a broad range of innovative and scientifically-proven products.
 

Conseil d'administration & Conseil de surveillance

PDG
Laurent Freixe
Conseil d'administration
Anna Manz, Béatrice Guillaume-Grabisch, David Rennie, Laurent Freixe, Leanne Geale, Sanjay Bahadur, Steven Wood Presley, Remy Ejel , David Xiqiang Zhang, Stefan Palzer, Bernard Meunier, Stephanie Pullings Hart, Anna Mohl, Guillaume Le Cunff, Lisa Gibby
Conseil de surveillance
Paul Bulcke, Dick Boer, Dinesh Paliwal, Hanne Jimenez de Mora, Lindiwe Majele Sibanda, Mark Schneider, Patrick Aebischer, Renato Fassbind, Luca Maestri, Chris Leong, Geraldine Matchett, Rainer Blair, Marie-Gabrielle Ineichen-Fleisch, Pablo Isla
 

Données de l'entreprise

Nom: Nestlé SA
Adresse: Avenue Nestlé 55,Vevey
Téléphone: +41-21-924-1111
Fax: +41-21-924-4800
Courriel: -
Internet: www.nestle.com/
Industrie: Consumer Goods
Secteur: Food and Beverage
Sous-secteur: Food Products
Fin de l'exercice financier: 31/12
Flotte libre: 96.83%
IPO date: 25/10/1905

Relations avec les investisseurs

Nom: Luca Borlini
Téléphone IR: +41 21 924 3509
IR-Fax: +41 (21) 924 4800
E-mail IR: ir@nestle.com

Calendrier de l'entreprise

CW 42 | 17/10/2024 Interim Report 3rd Quarter/9 Months
CW 7 | 13/02/2025 Report 4th Quarter
CW 16 | 16/04/2025 General Shareholder Meeting
 

Principaux actionnaires

Autres
 
94.96%
BlackRock, Inc.
 
5.04%